Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Cryotherapy Market by Product (Cryosurgery Devices, Localized Cryotherapy Devices, and Cryochambers & Cryosuanas), Application (Surgical Applications, Pain Management, Sports Medicine & Physiotherapy, and Beauty Applications), End User (Hospitals & Clinics, Cryotherapy Centers and Spas & Fitness Centers): Global Opportunity Analysis and Industry Forecast, 2021–2030

  • ALL4676869
  • 195 Pages
  • September 2021
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The global cryotherapy market was valued at $213 million in 2020, and is projected to reach $392 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.

Cryotherapy, or sometimes called cryogenic therapy, is a minimally invasive therapy that involves use of extremely cold temperatures to destroy diseased tissue. Cryotherapy is widely used in treatment of a variety of chronic conditions such as cancer, arthritis, pain, and skin conditions such as warts, skin tags, and dark spots. Cryosurgery offers various advantages over traditional surgeries including smaller incisions, shorter hospital stays, rapid wound healing, lesser pain & surgical wounds, and lower risk of complications.

In cryotherapy, a probe is inserted into the tissue next to the affected nerve to freeze the nerve. Freezing inactivates the nerve and, as a result, painful nerve irritation is relieved. Cryotherapy is a relatively safe and effective means of treating localized nerve irritation.

The growth of the global cryotherapy market is majorly driven rise in prevalence of chronic illness such arthritis and cancer and increasing applications in the healthcare sector are the major factors that growth in the global cryotherapy market. Furthermore, increase in minimal invasive procedures and rise in technological advancements provide significant opportunities for existing players and new entrants. However, lack of skilled workforces such as medical professionals, nurses, and doctors are limiting the market growth. In addition, limited access to cryotherapy and lack of awareness and lack of sufficient evidence regarding safety and effectiveness of whole-body cryotherapy products compared to existing treatment therapies inhibits the growth of the market hamper the market growth. In addition, development of new technologically advanced products and growth in focus on expanding cryotherapy applications are expected to provide lucrative opportunities for growth of the market.

The global cryotherapy market is classified on the basis of product, application, end user and region. By product, the market is divided into cryosurgery devices, localized cryotherapy devices, and cryochambers & cryosuanas. The cryosurgery devices segment is further segmented into hospitals & clinics, cryotherapy centers, and spas & fitness centers. The localized cryotherapy devices segment is further segmented into hospitals & clinics, cryotherapy centers, and spas & fitness centers. The cryochambers & cryosuanas is further segmented into hospitals & clinics, cryotherapy centers, and spas & fitness centers. By application, it is segmented into surgical applications, pain management, sports medicine & physiotherapy, and beauty applications. By end user, the market is categorized hospitals & clinics, cryotherapy centers, and spas & fitness centers. By region, the market is analyzed across, North America, Europe, Asia-Pacific and LAMEA.

The key players operating in the global enteral collagen peptide protein market include Impact Cryotherapy, Brymill Cryogenic Systems, Cooper Companies (Coopersurgical), Erbe Elektromedizin GmbH, Kriosystem Life, Medtronic Plc, Metrum Cryoflex, Cryoconcepts LP, US Cryotherapy and Zimmer Medizinsysteme GmbH, Cortex Technology, Mectronic Medicale S.r.l & Cryoalfa.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

• A comprehensive analysis of four regions is provided to determine the existing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global cryotherapy market.

KEY MARKET SEGMENTS

By Product

• Cryosurgery devices

o Hospital & Clinics

o Cryotherapy Centers

o Spas & Fitness Center

• Localized Cryotherapy Devices

o Hospital & Clinics

o Cryotherapy Centers

o Spas & Fitness Center

• Cryochambers & Cryosaunas

o Hospital & Clinics

o Cryotherapy Centers

o Spas & Fitness Center

By application

• Surgical Application

• Pain management

• Sports medicine & physiotherapy

• Beauty Application

By End User

• Hospital & Clinics

• Cryotherapy Centers

• Spas & Fitness Center

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

• Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific

• LAMEA

o Brazil

o South Africa

o Saudi Arabia

o Rest of LAMEA

KEY MARKET PLAYERS

• Impact Cryotherapy

• Brymill Cryogenic Systems

• Cooper Companies (Coopersurgical)

• Erbe Elektromedizin GmbH

• Kriosystem Life

• Medtronic Plc

• Metrum Cryoflex

• Cryoconcepts LP

• US Cryotherapy

• Zimmer Medizinsysteme GmbH.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

• Cortex Technology

• Mectronic Medicale S.r.l.

• Cryoalfa.

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning, 2020

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of chronic disease

3.5.1.2.Increase in number of non-invasive and minimally-invasive procedures.

3.5.1.3.Rise in Technological Advancements

3.5.2.Restraint

3.5.2.1.Limited access to cryotherapy and lack of awareness

3.5.3.Opportunity

3.5.3.1.Growing focus on expanding cryotherapy applications

3.5.4.Impact analysis

3.6.COVID-19 impact analysis on cryotherapy market

CHAPTER 4:CRYOTHERAPY MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Cryosurgery Devices

4.2.1.Key market trends, growth factors and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.2.4.Market size and forecast, by end user

4.3.Localized Cryotherapy Devices

4.3.1.Key market trends, growth factors and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

4.3.4.Market size and forecast, by end user

4.4.Cryochambers & Cryosaunas

4.4.1.Key market trends, growth factors and opportunities

4.4.2.Market size and forecast, by region

4.4.3.Market analysis, by country

4.4.4.Market size and forecast, by end user

CHAPTER 5:CRYOTHERAPY MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Surgical Application

5.2.1.Market size and forecast

5.2.2.Market analysis, by country

5.3.Pain Management.

5.3.1.Market size and forecast

5.3.2.Market analysis, by country

5.4.Sports medicine & Physiotherapy.

5.4.1.Market size and forecast

5.4.2.Market analysis, by country

5.5.Beauty application.

5.5.1.Market size and forecast

5.5.2.Market analysis, by country

CHAPTER 6:CRYOTHERAPY MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospital& clinics

6.2.1.Market size and forecast

6.2.2.Market analysis, by country

6.3.Cryotherapy Centers

6.3.1.Market size and forecast

6.3.2.Market analysis, by country

6.4.Spas & Fitness Centers

6.4.1.Market size and forecast

6.4.2.Market analysis, by country

CHAPTER 7:CRYOTHERAPY MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities

7.2.2.Market size and forecast, by country

7.2.3.Market size and forecast, by Product

7.2.4.Market size and forecast, by age group

7.2.5.Market size and forecast, by end user

7.2.6.U.S.

7.2.6.1.U.S. Market size and forecast, by Product

7.2.6.2.U.S. Market size and forecast, by age group

7.2.6.3.U.S. Market size and forecast, by end user

7.2.7.Canada

7.2.7.1.Canada Market size and forecast, by age group

7.2.7.2.Canada Market size and forecast, by end user

7.2.8.Mexico

7.2.8.1.Mexico Market size and forecast, by Product

7.2.8.2.Mexico Market size and forecast, by age group

7.2.8.3.Mexico Market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends and opportunities

7.3.2.Market size and forecast, by country

7.3.3.Market size and forecast, by Product

7.3.4.Market size and forecast, by age group

7.3.5.Market size and forecast, by end user

7.3.6.Germany

7.3.6.1.Germany Market size and forecast, by Product

7.3.6.2.Germany Market size and forecast, by age group

7.3.7.France

7.3.7.1.France Market size and forecast, by Product

7.3.7.2.France Market size and forecast, by age group

7.3.7.3.France Market size and forecast, by end user

7.3.8.UK

7.3.8.1.UK Market size and forecast, by Product

7.3.8.2.UK Market size and forecast, by age group

7.3.8.3.UK Market size and forecast, by end user

7.3.9.Italy

7.3.9.1.Italy Market size and forecast, by Product

7.3.9.2.Italy Market size and forecast, by age group

7.3.9.3.Italy Market size and forecast, by end user

7.3.10.Spain

7.3.10.1.Spain Market size and forecast, by Product

7.3.10.2.Spain Market size and forecast, by age group

7.3.10.3.Spain Market size and forecast, by end user

7.3.11.Rest of Europe

7.3.11.1.Rest of Europe Market size and forecast, by Product

7.3.11.2.Rest of Europe Market size and forecast, by age group

7.3.11.3.Rest of Europe Market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities

7.4.2.Market size and forecast, by country

7.4.3.Market size and forecast, by Product

7.4.4.Market size and forecast, by age group

7.4.5.Market size and forecast, by end user

7.4.6.Japan

7.4.6.1.Japan Market size and forecast, by Product

7.4.6.2.Japan Market size and forecast, by age group

7.4.6.3.Japan Market size and forecast, by end user

7.4.7.China

7.4.7.1.China Market size and forecast, by Product

7.4.7.2.China Market size and forecast, by age group

7.4.7.3.China Market size and forecast, by end user

7.4.8.Australia

7.4.8.1.Australia Market size and forecast, by Product

7.4.8.2.Australia Market size and forecast, by age group

7.4.8.3.Australia Market size and forecast, by end user

7.4.9.India

7.4.9.1.India Market size and forecast, by Product

7.4.9.2.India Market size and forecast, by age group

7.4.9.3.India Market size and forecast, by end user

7.4.10.South Korea

7.4.10.1.South korea Market size and forecast, by Product

7.4.10.2.South korea Market size and forecast, by age group

7.4.10.3.South korea Market size and forecast, by end user

7.4.11.Rest of Asia-Pacific

7.4.11.1.Rest of Asia-Pacific Market size and forecast, by Product

7.4.11.2.Rest of Asia-Pacific Market size and forecast, by age group

7.4.11.3.Rest of Asia-Pacific Market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends and opportunities

7.5.2.Market size and forecast, by country

7.5.3.Market size and forecast, by Product

7.5.4.Market size and forecast, by age group

7.5.5.Market size and forecast, by end user

7.5.6.Brazil

7.5.6.1.Brazil Market size and forecast, by age group

7.5.6.2.Brazil Market size and forecast, by age group

7.5.6.3.Brazil Market size and forecast, by end user

7.5.7.Saudi Arabia

7.5.7.1.Saudi Arabia Market size and forecast,by Product

7.5.7.2.Saudi Arabia Market size and forecast, by age group

7.5.7.3.Saudi Arabia Market size and forecast, by end user

7.5.8.South Africa

7.5.8.1.South Africa Market size and forecast, by product

7.5.8.2.South Africa Market size and forecast, by age group

7.5.8.3.South Africa Market size and forecast, by end user

7.5.9.Rest of LAMEA

7.5.9.1.Rest of LAMEA Market size and forecast, by Product

7.5.9.2.Rest of LAMEA Market size and forecast, by age group

7.5.9.3.Rest of LAMEA Market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.Brymill Cryogenic Systems

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Product portfolio

8.2.Cooper Companies. Inc (Coopersurgical)

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Operating business segments

8.2.4.Product Portfolio

8.2.5.Business performance

8.2.6.Key strategic moves and developments

8.3.CryoConcepts LP

8.3.1.Company overview

8.3.2.Company snapshot

8.3.3.Operating business segments

8.3.4.Product portfolio

8.4.Erbe Elektromedizin GmbH.

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Operating business segments

8.4.4.Product Portfolio

8.5.Impact Cryotherapy, Inc.

8.5.1.Company overview

8.5.2.Company snapshot

8.5.3.Operating business segments

8.5.4.Product Portfolio

8.6.Kriosystem Life & Care.

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Operating business segments

8.6.4.Product portfolio

8.7.Medtronic Plc.

8.7.1.Company overview

8.7.2.Company snapshot

8.7.3.Operating business segments

8.7.4.Product portfolio

8.7.5.Business performance

8.8.Metrum Cryoflex SP

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Operating business segments

8.8.4.Product portfolio

8.9.US Cryotherapy.

8.9.1.Company overview

8.9.2.Company snapshot

8.9.3.Operating business segments

8.9.4.Product portfolio

8.10.Zimmer Medizinsysteme, GmbH

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Operating business segments

8.10.4.Product portfolio

LIST OF TABLES

TABLE 01.CRYOTHERAPY MARKET, FOR PRODUCTS, BY REGION2020–2030 ($MILLION)

TABLE 02.CRYOTHERAPY MARKET FOR CRYOSURGERY DEVICES, BY REGION, 2020–2030 ($MILLION)

TABLE 03.CRYOTHERAPY MARKET FOR CRYOSURGERY DEVICES, BY END USER, 2020–2030 ($MILLION)

TABLE 04.CRYOTHERAPY MARKET FOR LOCALIZED CRYOTHERAPY DEVICE, BY REGION, 2020–2030 ($MILLION)

TABLE 05.CRYOTHERAPY MARKET FOR LOCALIZED CRYOTHERAPY DEVICES, BY END USER, 2020–2030 ($MILLION)

TABLE 06.CRYOTHERAPY MARKET FOR CRYOCHAMBERS & CRYOSAUNAS, BY REGION, 2020–2030 ($MILLION)

TABLE 07.CRYOTHERAPY MARKET FOR CRYOCHAMBERS & CRYOSAUNAS, BY END USER, 2020–2030 ($MILLION)

TABLE 08.GLOBAL CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030($MILLION)

TABLE 09.SURGICAL APPLICATIONS CRYOTHERAPY MARKET, BY REGION, 2020-2030($MILLION)

TABLE 10.PAIN MANAGEMENT CRYOTHERAPY MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 11.SPORTS MEDICINE & PHYSIOTHERAPY CRYOTHERAPY MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 12.BEAUTY APPLICATION CRYOTHERAPY MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 13.CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 14.CRYOTHERAPY MARKET FOR HOSPITAL & CLINICS, BY REGION, 2020–2030 ($MILLION)

TABLE 15.CRYOTHERAPY MARKET FOR CRYOTHERAPY CENTERS, BY REGION, 2020–2030 ($MILLION)

TABLE 16.CRYOTHERAPY MARKET FOR SPAS AND FITNESS CENTER, BY REGION, 2020–2030 ($MILLION)

TABLE 17.CRYOTHERAPY MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 18.NORTH AMERICA CRYOTHERAPY MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 19.NORTH AMERICA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 20.NORTH AMERICA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 21.NORTH AMERICA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 22.U.S. CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 23.U.S. CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 24.U.S. CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 25.CANADA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 26.CANADA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 27.CANADA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 28.MEXICO CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 29.MEXICO CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 30.MEXICO CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 31.EUROPE CRYOTHERAPY MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 32.EUROPE CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 33.EUROPE CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 34.EUROPE CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 35.GERMANY CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 36.GERMANY CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 37.FRANCE CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 38.FRANCE CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 39.FRANCE CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 40.UK CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 41.UK CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 42.UK CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 43.ITALY ENTERAL COLLAGEN PEPTIDEP ROTEIN MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 44.ITALY CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 45.ITALY CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 46.SPAIN CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 47.SPAIN CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 48.SPAIN CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 49.REST OF EUROPE CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 50.REST OF EUROPE CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 51.REST OF EUROPE CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 52.ASIA-PACIFIC CRYOTHERAPY MARKET, BY COUNTRY, 2020–2030($MILLION)

TABLE 53.ASIA-PACIFIC CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 54.ASIA-PACIFIC CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2039 ($MILLION)

TABLE 55.ASIA-PACIFIC CRYOTHERAPY MARKET, BY END USER, 2020–2030($MILLION)

TABLE 56.JAPAN CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 57.JAPAN CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 58.JAPAN CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 59.CHINA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 60.CHINA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 61.CHINA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 62.AUSTRALIA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 63.AUSTRALIA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 64.AUSTRALIA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 65.INDIA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 66.INDIA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 67.INDIA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 68.SOUTH KOREA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 69.SOUTH KOREA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 70.SOUTH KOREA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 71.REST OF ASIA-PACIFIC CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 72.REST OF ASIA-PACIFIC CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 73.REST OF ASIA-PACIFIC CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 74.LAMEA CRYOTHERAPY MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 75.LAMEA CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 76.LAMEA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 77.LAMEA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 78.BRAZIL CRYOTHERAPY MARKET, BY PRODUCT, 2020–2030 ($MILLION)

TABLE 79.BRAZIL CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 80.BRAZIL CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 81.SAUDI ARABIA CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 82.SAUDI ARABIA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 83.SAUDI ARABIA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 84.SOUTH AFRICA CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 85.SOUTH AFRICA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 86.SOUTH AFRICA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 87.REST OF LAMEA CRYOTHERAPY MARKET,BY PRODUCT, 2020–2030 ($MILLION)

TABLE 88.REST OF LAMEA CRYOTHERAPY MARKET, BY AGE GROUP, 2020–2030 ($MILLION)

TABLE 89.REST OF LAMEA CRYOTHERAPY MARKET, BY END USER, 2020–2030 ($MILLION)

TABLE 90.BRYMILL: COMPANY SNAPSHOT

TABLE 91.BRYMILL: OPERATING SEGMENTS

TABLE 92.BRYMILL: PRODUCT PORTFOLIO

TABLE 93.COOPER: COMPANY SNAPSHOT

TABLE 94.COOPER: OPERATING SEGMENTS

TABLE 95.COOPER: PRODUCT PORTFOLIO

TABLE 96.CRYOCONCEPTS: COMPANY SNAPSHOT

TABLE 97.CRYOCONCEPTS: OPERATING SEGMENTS

TABLE 98.CRYOCONCEPTS: PRODUCT PORTFOLIO

TABLE 99.ERBE: COMPANY SNAPSHOT

TABLE 100.ERBE: BUSINESS SEGMENT

TABLE 101.IMPACT CRYOTHERAPY: COMPANY SNAPSHOT

TABLE 102.IMPACT CRYOTHERAPY, INC: BUSINESS SEGMENT

TABLE 103.KRIOSYSTEM: COMPANY SNAPSHOT

TABLE 104.KRIOSYSTEM: OPERATING SEGMENTS

TABLE 105.KRIOSYSTEM: PRODUCT PORTFOLIO

TABLE 106.MEDTRONIC: COMPANY SNAPSHOT

TABLE 107.MEDTRONIC: OPERATING SEGMENTS

TABLE 108.MEDTRONIC: PRODUCT PORTFOLIO

TABLE 109.METRUM: COMPANY SNAPSHOT

TABLE 110.METRUM: OPERATING SEGMENTS

TABLE 111.METRUM: PRODUCT PORTFOLIO

TABLE 112.CRYOTHERAPY: COMPANY SNAPSHOT

TABLE 113.CRYOTHERAPY: OPERATING SEGMENTS

TABLE 114.CRYOTHERAPY: PRODUCT PORTFOLIO

TABLE 115.ZIMMER: COMPANY SNAPSHOT

TABLE 116.ZIMMER: OPERATING SEGMENTS

TABLE 117.ZIMMER: PRODUCT PORTFOLIO

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750